342 related articles for article (PubMed ID: 34383993)
1. Alpha Synuclein only Forms Fibrils In Vitro when Larger than its Critical Size of 70 Monomers.
Sanchez SE; Whiten DR; Meisl G; Ruggeri FS; Hidari E; Klenerman D
Chembiochem; 2021 Oct; 22(19):2867-2871. PubMed ID: 34383993
[TBL] [Abstract][Full Text] [Related]
2. α-Synuclein aggregation at low concentrations.
Afitska K; Fucikova A; Shvadchak VV; Yushchenko DA
Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):701-709. PubMed ID: 31096048
[TBL] [Abstract][Full Text] [Related]
3. Correlation between Cellular Uptake and Cytotoxicity of Fragmented α-Synuclein Amyloid Fibrils Suggests Intracellular Basis for Toxicity.
Zhang X; Wesén E; Kumar R; Bernson D; Gallud A; Paul A; Wittung-Stafshede P; Esbjörner EK
ACS Chem Neurosci; 2020 Feb; 11(3):233-241. PubMed ID: 31894960
[TBL] [Abstract][Full Text] [Related]
4. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
Conway KA; Harper JD; Lansbury PT
Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
[TBL] [Abstract][Full Text] [Related]
5. Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson's disease.
Lobanova E; Whiten D; Ruggeri FS; Taylor CG; Kouli A; Xia Z; Emin D; Zhang YP; Lam JYL; Williams-Gray CH; Klenerman D
Brain; 2022 Apr; 145(2):632-643. PubMed ID: 34410317
[TBL] [Abstract][Full Text] [Related]
6. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.
Froula JM; Castellana-Cruz M; Anabtawi NM; Camino JD; Chen SW; Thrasher DR; Freire J; Yazdi AA; Fleming S; Dobson CM; Kumita JR; Cremades N; Volpicelli-Daley LA
J Biol Chem; 2019 Jul; 294(27):10392-10406. PubMed ID: 31142553
[TBL] [Abstract][Full Text] [Related]
7. Identification and nanomechanical characterization of the fundamental single-strand protofilaments of amyloid α-synuclein fibrils.
Ruggeri FS; Benedetti F; Knowles TPJ; Lashuel HA; Sekatskii S; Dietler G
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7230-7235. PubMed ID: 29941606
[TBL] [Abstract][Full Text] [Related]
8. Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation.
Buell AK; Galvagnion C; Gaspar R; Sparr E; Vendruscolo M; Knowles TP; Linse S; Dobson CM
Proc Natl Acad Sci U S A; 2014 May; 111(21):7671-6. PubMed ID: 24817693
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of Alpha-Synuclein Amyloid Fibrils Depends on Ionic Strength and Protein Concentration.
Ziaunys M; Sakalauskas A; Mikalauskaite K; Smirnovas V
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830264
[TBL] [Abstract][Full Text] [Related]
10. Covalent α-synuclein dimers: chemico-physical and aggregation properties.
Pivato M; De Franceschi G; Tosatto L; Frare E; Kumar D; Aioanei D; Brucale M; Tessari I; Bisaglia M; Samori B; de Laureto PP; Bubacco L
PLoS One; 2012; 7(12):e50027. PubMed ID: 23272053
[TBL] [Abstract][Full Text] [Related]
11. The effect of fluorescent labeling on α-synuclein fibril morphology.
Mučibabić M; Apetri MM; Canters GW; Aartsma TJ
Biochim Biophys Acta; 2016 Oct; 1864(10):1419-27. PubMed ID: 27475048
[TBL] [Abstract][Full Text] [Related]
12. The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation.
Lorenzen N; Nielsen SB; Buell AK; Kaspersen JD; Arosio P; Vad BS; Paslawski W; Christiansen G; Valnickova-Hansen Z; Andreasen M; Enghild JJ; Pedersen JS; Dobson CM; Knowles TP; Otzen DE
J Am Chem Soc; 2014 Mar; 136(10):3859-68. PubMed ID: 24527756
[TBL] [Abstract][Full Text] [Related]
13. Cofilin 1 promotes the aggregation and cell-to-cell transmission of α-synuclein in Parkinson's disease.
Yan M; Meng L; Dai L; Zhang X; Chen G; Zheng Y; Zha Y; Zeng Y; Zhang Z
Biochem Biophys Res Commun; 2020 Sep; 529(4):1053-1060. PubMed ID: 32819564
[TBL] [Abstract][Full Text] [Related]
14. All-or-none amyloid disassembly via chaperone-triggered fibril unzipping favors clearance of α-synuclein toxic species.
Franco A; Gracia P; Colom A; Camino JD; Fernández-Higuero JÁ; Orozco N; Dulebo A; Saiz L; Cremades N; Vilar JMG; Prado A; Muga A
Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34462355
[TBL] [Abstract][Full Text] [Related]
15. Small soluble α-synuclein aggregates are the toxic species in Parkinson's disease.
Emin D; Zhang YP; Lobanova E; Miller A; Li X; Xia Z; Dakin H; Sideris DI; Lam JYL; Ranasinghe RT; Kouli A; Zhao Y; De S; Knowles TPJ; Vendruscolo M; Ruggeri FS; Aigbirhio FI; Williams-Gray CH; Klenerman D
Nat Commun; 2022 Sep; 13(1):5512. PubMed ID: 36127374
[TBL] [Abstract][Full Text] [Related]
16. Analysis of sheep α-synuclein provides a molecular strategy for the reduction of fibrillation.
Bickle L; Hopwood JJ; Karageorgos L
Biochim Biophys Acta Proteins Proteom; 2017 Mar; 1865(3):261-273. PubMed ID: 28007442
[TBL] [Abstract][Full Text] [Related]
17. How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology.
Kumar ST; Jagannath S; Francois C; Vanderstichele H; Stoops E; Lashuel HA
Neurobiol Dis; 2020 Dec; 146():105086. PubMed ID: 32971232
[TBL] [Abstract][Full Text] [Related]
18. Nanoscale imaging of individual amyloid aggregates extracted from brains of Alzheimer and Parkinson patients reveals presence of lipids in α-synuclein but not in amyloid β
Zhaliazka K; Kurouski D
Protein Sci; 2023 Apr; 32(4):e4598. PubMed ID: 36823759
[TBL] [Abstract][Full Text] [Related]
19. Cross-seeding of alpha-synuclein aggregation by amyloid fibrils of food proteins.
Vaneyck J; Segers-Nolten I; Broersen K; Claessens MMAE
J Biol Chem; 2021; 296():100358. PubMed ID: 33539920
[TBL] [Abstract][Full Text] [Related]
20. Partially oxidized DJ-1 inhibits α-synuclein nucleation and remodels mature α-synuclein fibrils in vitro.
Kumar R; Kumar S; Hanpude P; Singh AK; Johari T; Majumder S; Maiti TK
Commun Biol; 2019; 2():395. PubMed ID: 31701024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
